Holder snapshot 7 signals
Share change
+4,885,043
Put/Call ratio
296%
SEC-reported price per share
$73.00
Number of holders
120
Value change
+$372,239,794
Number of buys
99
Open additional details 1 more signal available
Number of sells
34
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
62,650,155

Security key

78667J108

Report period

Q2 2015

Institutions

120

Top holders

0

Ownership snapshot

Top reported holders of SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Archived quarter

Historical 13F summary for Q2 2015

This older quarter remains available as an indexed ownership summary. Detailed holder rows are no longer kept in the hot table for this period.

There are no holders of SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") as of Q2 2015.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .